The Effects of Medication on Cognition in Long-Term Care

Abstract

This article emphasizes the need to consider the role of medications when providing speech-language pathology services to a person with cognitive decline. This is particularly true when working with older adults. Many older adults take multiple medications that may have a direct effect on cognitive ability and as a result, on the success of rehabilitation efforts.

Keywords

Polypharmacy - neurotransmitters - benzodiazepines

• References

• 1 Iversen LL, Iversen SD, Bloom FE, Roth RH. Introduction to Neuropsychopharmacology. Oxford, UK: Oxford University Press; 2009
• 2 Emilien G, Durlach C, Minaker KL, Winblad B, Gauthier S, Maloteaux J. Alzheimer Disease: Neuropsychology and Pharmacology. Berlin, Germany: Birkhauser Verlag; 2004
• 3 Alzheimer's Association. Latest Facts and Figures. Alzheimer's Association. 2011. Available at http://www.alz.org/alzheimers_disease_facts_and_figures.asp . Accessed January 7, 2013
• 4 Shirley KL. Dementia. In: Shaffer CL, Gal P, Ransom JL, , et al, eds. Pharmacotherapy Self Assessment Program. Book 7: Neurology and Psychiatry. 4th ed. Kansas City, MI: American College of Clinical Pharmacy; 2002: 167-202
• 5 Chen JJ. Movement disorders: Parkinson's disease and essential tremor. In: Pharmacotherapy Self-Assessment Program. Book 7: Neurology and Psychiatry. Kansas City, MI: American College of Clinical Pharmacy; 2002: 1-42
• 6 Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-1139
• 7 Ciccone CD. Pharmacology in Rehabilitation. 3rd ed. Philadelphia, PA: FA Davis Co.; 2002: 3-58
• 8 Gadson B. Pharmacology for Physical Therapists. Philadelphia, PA: Elsevier; 2006
• 9 Malone T. Physical and Occupational Therapy: Drug Implications for Practice. Philadelphia, PA: JB Lippincott; 1989
• 10 Carl L, Gallo J, Johnson P. Practical Pharmacology in Rehabilitation: Effect of Medications on Therapy. Champaign, IL: Human Kinetics; ; in press
• 11 Johnson P. Drug interactions with antipsychotic medications in the population with dementia. ASHA Special Interest Division 13. Dysphagia Newsletter 2001; 9: 25-27
• 12 Carl LC, Johnson PR. Drugs and Dysphagia: How Medications Can Affect Eating and Swallowing. Austin, TX: ProEd Publications; 2006
• 13 Blumenthal DK, Garrison JC. Pharmacodynamics: Molecular Mechanisms of Drug Action. In: Brunton LL, Chabner BA, Knollman BC, , eds. Goodman and Gillman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011: 41-72
• 14 Bauer LA In: Clinical Pharmacokinetics and Pharmacodynamic. DiPiro JT, Talbert RL, Yee GC, Matske GR, Wells BG, , et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 5th ed. Stamford, CT: Appleton and Lange; 2002: 33-55
• 15 Buxton IL, Benet LZ. Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism and Elimination. In: Brunton LL, Chabner BA, Knollman BC, , eds. Goodman and Gillman's The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 2002: 17-39
• 16 UC Health Centers of America. A new approach to healthcare. UC Health Centers of America 2012. Available at: http://uppercervicalcare.com/What-is-UC-Care/A-New-Health-Care-Approach . Accessed December 2012
• 17 Farrell B, Szeto W, Shamji S. Drug-related problems in the frail elderly. Can Fam Physician 2011; 57: 168-169
• 18 Modewal A. Prescription medication in the elderly. Net wellness. Available at: http://www.netwellness.org/healthtopics/aging/faq16.cfm . Accessed December 2012
• 19 Gurvich T. Cunningham. Appropriate Use of Psychotropic Drugs in Nursing. American Family Physician 2000; 611437-1446
• 20 Baldessarini RJ, Tarazi FI. Drugs and the Treatment of Psychiatric Disorders: Psychosis and Mania. In: Hardman JG, Limberd LE, Gillman AG, , eds. Goodman and Gillman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2000: 485-520
• 21 Kando JC, Wells BG, Hayes PE. Depressive disorders. In: DiPiro JT, Talbert RL, Yee GC, Matske GR, Wells BG, Posey LM, , eds. Pharmacotherapy: A Pathophysiologic Approach. Stamford, CT: Appleton and Lange; 2002: 1243-1264
• 22 Crismon ML. Dormson PG. Schizophrenia. In: DiPiro JT, Talbert RL, Yee GE, Matzke GR, Wells BG, Posey LM, , eds. Pharmacotherapy: A Pathophysiologic Approach. Stamford, CT: Appleton and Lange; 2002: 1219-1242
• 23 Hebel SK. Antipsychotic medications. In: Wolters Kluwer. Drug Facts and Comparisons. St. Louis, MI: Facts and Comparisons Company; 2002: 561-573
• 24 Grunwald PE. Supportive care II. In: Pharmacotherapy Self-Assessment Program. Book 10: Hematology and Oncology. Kansas City, MI: American College of Clinical Pharmacy; 2003: 113-135
• 25 Mitchell D. Common drugs used by older adults cause cognitive decline, and worse. Emax Health. Available at: http://www.emaxhealth.com/1275/common_drugs_used_older_adults_cause_cognitivedecline_worse . Accessed December 2012
• 26 Noll C, Boustani M, Limbil T, Ott C, Fox C, Maidment I, Schubert CC, Munger S, Fick D, Miller D, Gulati R. The cognitive impact of anticholinergics: a clinical review. Clinical Interventions in Aging 2009; 4: 225-233
• 27 Moyer MW. It's not dementia, it's your heart medication: cholesterol drugs and memory. Scientific American. 2010. Available at http://www.ScientificAmerican.com/article.cfm?id=its-not-dementia-it's-your-heart-medication . Accessed December 2012
• 28 Wright RM, Roumani YF, Boudreau R , et al. Impact of central nervous system (CNS) medication use on cognition decline in community dwelling older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2009; 57: 243-250